WHO ICTRP trial
Clinical metabolomics study on the intervention of hepatolenticular degeneration…
ChiCTR2500098794 · Chinese Clinical Trial Registry (ChiCTR) · Not Recruiting
Key facts
| Trial ID | ChiCTR2500098794 |
|---|---|
| Public title | Clinical metabolomics study on the intervention of hepatolenticular degeneration with Ganduling capsules |
| Scientific title | Clinical metabolomics study on the intervention of hepatolenticular degeneration with Ganduling capsules |
| Primary sponsor | The First Affiliated Hospital of Anhui University of Traditional Chinese Medicine |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Not Recruiting |
| Study type | Interventional study |
| Phase | 1 |
| Countries | China |
| Conditions | Wilson Disease |
| Interventions | Gandouling intervention group:The intervention group of Gandouling capsules on the basis of the HLD case-control group, liver douling capsules(0.3g/capsule, prepared by the Preparation Center of the First Affiliated Hospital of Anhui… |
| Registration date | Mar 13, 2025 |
| Target size | Gandouling intervention group:40;control group:40 |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: